Nikki Cheng

Department of Pathology, University of Kansas Medical Center

Affiliated withUniversity of Kansas Medical Center

Research Area

Biography

Nikki Cheng has not added Biography.
If you are Nikki Cheng and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 14	2011

Other Publications

Article	Year
The ephrins and Eph receptors in angiogenesis. Cytokine & growth factor reviews\| PubMed ID: 11750881	2002
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene\| PubMed ID: 12370823	2002
Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis. Molecular cancer research : MCR\| PubMed ID: 12496364	2002
Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors. Neoplasia (New York, N.Y.)\| PubMed ID: 14670182	2003
Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene\| PubMed ID: 15856015	2005
Genomic and proteomic analysis of mammary tumors arising in transgenic mice. Journal of proteome research\| PubMed ID: 16335954	2005
Inhibition of retinal neovascularization by soluble EphA2 receptor. Experimental eye research\| PubMed ID: 16359662	2006
Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis. Cancer research\| PubMed ID: 17495323	2007
Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells. Cancer biology & therapy\| PubMed ID: 17495520	2007
Identification of novel Smad2 and Smad3 associated proteins in response to TGF-beta1. Journal of cellular biochemistry\| PubMed ID: 18729074	2008
Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion. Molecular cancer research : MCR\| PubMed ID: 18922968	2008
Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer. The Journal of clinical investigation\| PubMed ID: 19451693	2009
Quantitative analysis of the secretome of TGF-beta signaling-deficient mammary fibroblasts. Proteomics\| PubMed ID: 20405477	2010
Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms... Neoplasia (New York, N.Y.)\| PubMed ID: 20454514	2010
Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting. Cancer therapy\| PubMed ID: 20651940	2009
Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression. Clinical & experimental metastasis\| PubMed ID: 21374085	2011